Preferential Cochleotoxicity of Cisplatin
Cisplatin-induced ototoxicity in humans is more predominant in the cochlea than in the vestibule. Neither definite nor substantial vestibular dysfunction after cisplatin treatment has been consistently reported in the current literature. Inner ear hair cells seem to have intrinsic characteristics th...
Main Authors: | Pattarawadee Prayuenyong, David M. Baguley, Corné J. Kros, Peter S. Steyger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2021.695268/full |
Similar Items
-
Vestibulotoxicity Associated With Platinum-Based Chemotherapy in Survivors of Cancer: A Scoping Review
by: Pattarawadee Prayuenyong, et al.
Published: (2018-09-01) -
Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review
by: Pattarawadee Prayuenyong, et al.
Published: (2020-05-01) -
Topical gentamicin-induced acute vestibulopathy: A case report
by: Teik Beng Lau, et al.
Published: (2023-05-01) -
Ratlarda cisplatin ototoksisitesinde adrenomedüllinin etkinliği
by: Nagihan BİLAL, et al.
Published: (2019-06-01) -
Potential Mechanisms Underlying Inflammation-Enhanced Aminoglycoside-Induced Cochleotoxicity
by: Meiyan Jiang, et al.
Published: (2017-11-01)